Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture.

Whitehurst B, Eversgerd C, Flister M, Bivens CM, Pickett B, Zawieja DC, Ran S.

Lymphat Res Biol. 2006;4(3):119-42.

PMID:
17034293
2.

The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mansel RE, Mason MD.

Int J Mol Med. 2005 Oct;16(4):723-8.

PMID:
16142411
3.

Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1.

Kilic N, Oliveira-Ferrer L, Neshat-Vahid S, Irmak S, Obst-Pernberg K, Wurmbach JH, Loges S, Kilic E, Weil J, Lauke H, Tilki D, Singer BB, Ergün S.

Blood. 2007 Dec 15;110(13):4223-33. Epub 2007 Aug 30.

5.

Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.

Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S.

Int J Cancer. 2007 Nov 15;121(10):2181-91.

6.

Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.

Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y, Manabe T.

Pancreas. 2007 May;34(4):444-51.

PMID:
17446844
7.

The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.

Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Ylä-Herttuala S, Wedge SR, Jürgensmeier JM, Alitalo K.

Cancer Res. 2008 Jun 15;68(12):4754-62. doi: 10.1158/0008-5472.CAN-07-5809.

8.

The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.

Al-Rawi MA, Watkins G, Mansel RE, Jiang WG.

Int J Oncol. 2005 Sep;27(3):721-30.

PMID:
16077922
9.

Inhibition of proliferation, sprouting, tube formation and Tie2 signaling of lymphatic endothelial cells by the histone deacetylase inhibitor SAHA.

Cheng HT, Hung WC.

Oncol Rep. 2013 Aug;30(2):961-7. doi: 10.3892/or.2013.2523. Epub 2013 Jun 7.

PMID:
23754070
12.

Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis.

Shin JW, Huggenberger R, Detmar M.

Blood. 2008 Sep 15;112(6):2318-26. doi: 10.1182/blood-2008-05-156331. Epub 2008 Jul 9.

13.

CD34+ VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells.

Tan YZ, Wang HJ, Zhang MH, Quan Z, Li T, He QZ.

J Cell Mol Med. 2014 Mar;18(3):422-33. doi: 10.1111/jcmm.12233. Epub 2014 Jan 22.

14.

Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S.

Blood. 2010 Jan 14;115(2):418-29. doi: 10.1182/blood-2008-12-196840. Epub 2009 Nov 9.

15.

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.

Lohela M, Bry M, Tammela T, Alitalo K.

Curr Opin Cell Biol. 2009 Apr;21(2):154-65. doi: 10.1016/j.ceb.2008.12.012. Epub 2009 Feb 21. Review.

PMID:
19230644
16.

Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells.

Lin CI, Chen CN, Huang MT, Lee SJ, Lin CH, Chang CC, Lee H.

Cell Mol Life Sci. 2008 Sep;65(17):2740-51. doi: 10.1007/s00018-008-8314-9.

PMID:
18642114
17.

Lymphangiogenic growth factors, receptors and therapies.

Lohela M, Saaristo A, Veikkola T, Alitalo K.

Thromb Haemost. 2003 Aug;90(2):167-84. Review.

PMID:
12888864
18.

Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.

Hwang-Bo J, Yoo KH, Park JH, Jeong HS, Chung IS.

Int J Cancer. 2012 Jul 15;131(2):298-309. doi: 10.1002/ijc.26353. Epub 2011 Aug 30.

19.

Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.

Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, Jackson DG, Yla-Herttuala S, Alitalo K.

Circ Res. 2001 Mar 30;88(6):623-9. Erratum in: Circ Res 2001 Jul 6;89(1):E15.

20.

Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.

Lohela M, Heloterä H, Haiko P, Dumont DJ, Alitalo K.

Am J Pathol. 2008 Dec;173(6):1891-901. doi: 10.2353/ajpath.2008.080378. Epub 2008 Nov 6.

Supplemental Content

Support Center